Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 7351-7360 Newer>

Pharmaceutical Executive April 1, 2011	The Big Business of Boosting Performance Dutch-based DSM N.V. is seeking innovative ways to partner through bolstering manufacturing.
Pharmaceutical Executive April 1, 2011	How US Health Reform Is Hitting Canada Canada's Russell Williams, of Rx&D, talks about the impact of US health reform on his role as chief spokesman for the country's R&D industry.
Pharmaceutical Executive April 1, 2011	HBA Woman of the Year: Freda Lewis-Hall The determination of Pfizer's Freda Lewis-Hall has enabled her to find a ray of hope in every situation she's encountered.
Pharmaceutical Executive April 1, 2011	Special Section: Pharma Meetings Merck mounts pharma's first virtual symposium and interactive poster session.
Pharmaceutical Executive April 1, 2011 William Looney	Platforms for Peerless Performance A true performance culture has to focus on the mundane as much as the sublime.
Pharmaceutical Executive April 1, 2011 David Quigley	The Death of a Sales Model? These days, learning to strategically do more with less can keep your sales force performing at a high level.
Pharmaceutical Executive April 1, 2011	Dalli's Formula Fails the Efficacy Test EU leadership on pharma policy leaves many wondering of the right man is at the helm.
Pharmaceutical Executive April 1, 2011	Revisiting Reform Courts, Congress review policies and programs shaping drug costs and access.
Pharmaceutical Executive April 1, 2011	Bridging the HCP-Patient Gap Here's what's necessary to bridge the gap between the patient revolution and healthcare provider in the 21st century.
Pharmaceutical Executive April 1, 2011	Off-Label But On Point? Use of off-label drugs is a balancing act for physicians, and poses even more problems for pharma. The FDA is moving slowly to help.
<Older 7351-7360 Newer> Return to current articles.